A New Way to Fund Orphan Drug Discovery
Orphan drug development is more difficult to fund as they tend to be required for the treatment of diseases that are rare compared with illnesses such as heart disease, asthma etc - such as to treat aspergillosis. If the market for these drugs is small then there is likely to be difficulty getting an adequate return on sales to cover the huge cost of development - at the very least there is a
0 Response to "A New Way to Fund Orphan Drug Discovery"
Post a Comment